Retigabine (Ezogabine) DiHCl

M.F. C₁₆H₁₈FN₃O₂. ₂ HCl
M.W. 303.34 2 36.46
CAT# AR-R01425
CAS# 150812-13-8
Axios Research stands at the forefront of pharmaceutical reference standards ingenuity, providing high quality Retigabine (Ezogabine Reference Standards. These include both pharmacopeial and non-pharmacopeial Retigabine (Ezogabine impurities, metabolites, stable isotope products, and nitrosamines. Our Retigabine (Ezogabine impurity reference standards are essential for pharmaceutical research, aiding in product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They are also used in identifying unknown impurities and evaluating genotoxic potential. Our Retigabine (Ezogabine related products are meticulously characterized and come with a comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards.
M.F. C₁₆H₁₈FN₃O₂. ₂ HCl
M.W. 303.34 2 36.46
CAT# AR-R01425
CAS# 150812-13-8
M.F. C₁₆H₁₃FN₃O₂D₅. ₂ HCl
M.W. 308.37 2 36.46
CAT# AR-R01426
CAS# 1432063-93-8
M.F. C₁₅H₁₆FN₃O . ₂ HCl
M.W. 273.31 2 36.46
CAT# AR-R01429
CAS# 229970-68-7 (free base)
M.F. C₁₈H₁₅FN₃O₃D₅
M.W. 350.41
CAT# AR-R01428
CAS# 1028277-75-9 (non-labelled)
Can't find what you are looking for?
Inquire Now